Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Mankind Pharma Ltd
Mankind Pharma Ltd

Mankind Pharma Ltd (MANKIND) Share Price

  • Sector: Pharmaceuticals (Large Cap)
  • Volume: 4,59,518
Apr 25, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹2,557.50
₹-41.70 (-1.60%)
2,525.00Low
Today’s Performance
2,642.20High
1,901.05Low
52 Week’s Performance
3,054.80High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-1.60%
  • 1 Week0.68%
  • 1 Month9.57%
  • 3 Months3.68%
  • 6 Months3.79%
  • 1 Year8.38%
  • 3 Years-%
  • 5 Years-%

bt_logoPeer Comparison

Price

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.50
  • 52-Week Low (₹)1,901.05
  • 52-Week High (₹)3,054.80
  • Price-to-Book (X)*7.92
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*52.60
  • Earnings Per Share (₹)49.48
  • Market Cap (₹ Cr.)*1,07,237.41
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices3:40Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices
Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report19:05Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report
India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop8:47India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop
Market Skittish Ahead Of Possible Indian Military Response To Pahalgam Carnage29:33Market Skittish Ahead Of Possible Indian Military Response To Pahalgam Carnage
How to Secure Growth in the Next Decade: Kenneth Andrade’s Global Portfolio Insights1:30How to Secure Growth in the Next Decade: Kenneth Andrade’s Global Portfolio Insights
US Based Jewellery Brand Angara Enters India | To Open 100 Stores By 2030 | Aditi & Ankur Daga22:02US Based Jewellery Brand Angara Enters India | To Open 100 Stores By 2030 | Aditi & Ankur Daga
India Eyes Trade Gains As Trump Softens Tariff Stance On China2:01India Eyes Trade Gains As Trump Softens Tariff Stance On China
New Tax On Luxury! Helicopters, Handbags & High-End Hobbies Now Cost More5:24New Tax On Luxury! Helicopters, Handbags & High-End Hobbies Now Cost More
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today46:35Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
China’s ‘Secret Soldiers’ Invade And Turn US Opinion On Tariffs, Target Shoppers3:46China’s ‘Secret Soldiers’ Invade And Turn US Opinion On Tariffs, Target Shoppers
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

25 Jan, 2024BUY
SOCIETE GENERALE
Qty312695
Average Price₹2060.65
25 Jan, 2024BUY
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND
Qty82213
Average Price₹2060.65
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty312695
Average Price₹2060.65
25 Jan, 2024SELL
SOCIETE GENERALE
Qty110905
Average Price₹2060.65
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty82213
Average Price₹2060.65
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Mankind Pharma Ltd share price previously?
Mankind Pharma Ltd share price was down by -1.60% from the previous closing price of ₹2,599.20.
Who are peers of Mankind Pharma Ltd?
The peers of Mankind Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Mankind Pharma Ltd?
The promotor/promotors of Mankind Pharma Ltd are RAMESH CHAND JUNEJA, RAJEEV JUNEJA, SHEETAL ARORA, TILOKCHAND PUNAMCHAND OSTWAL, Bharat Anand, SATISH KUMAR SHARMA, Vivek Kalra, Vijaya Sampath, Hitesh Kumar Jain.
What has been 52-week high of Mankind Pharma Ltd stocks?
The highest price of Mankind Pharma Ltd stock is ₹3,054.80 in the last 52-week.
What is the share price of Mankind Pharma Ltd (MANKIND) today on NSE?
As on Apr 25, 2025 Mankind Pharma Ltd (MANKIND)’s share price on NSE is Rs 2557.5
What is the market cap of Mankind Pharma Ltd (MANKIND)?
The current market capitalisation of Mankind Pharma Ltd (MANKIND) is 1,07,237.41 crores
What is Mankind Pharma Ltd Share symbol?
The symbol of Mankind Pharma Ltd is MANKIND.
What is the PE ratio of Mankind Pharma Ltd (MANKIND)?
The current PE ratio of Mankind Pharma Ltd (MANKIND) is 52.60.
What is the PB ratio of Mankind Pharma Ltd (MANKIND)?
The current PB ratio of Mankind Pharma Ltd (MANKIND) is 7.92.
Today’s High & Low share prices of Mankind Pharma Ltd (MANKIND) on NSE?
Today, the share price of Mankind Pharma Ltd (MANKIND) on NSE touched a high of Rs 2642.2 and a low of Rs 2525
What price did Mankind Pharma Ltd (MANKIND) shares open on the NSE today?
On NSE, the share price of Mankind Pharma Ltd (MANKIND) opened at Rs 2605
What is the 52-week high of Mankind Pharma Ltd (MANKIND)?
The 52-week high price of Mankind Pharma Ltd (MANKIND) is Rs 3,054.80
What is the 52-week low of Mankind Pharma Ltd (MANKIND)?
The 52-week low price of Mankind Pharma Ltd (MANKIND) is Rs 1,901.05

bt_logoAbout Mankind Pharma

Mankind Pharma Ltd, incorporated in the year 1991, has its registered office in 208 Okhla Industrial Estate, Phase-III, New Delhi, New Delhi, 110020, 91-11-47476600. The main industry in which Mankind Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Mankind Pharma Ltd is/are S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co. In the main management, RAMESH CHAND JUNEJA is chairman and Hitesh Kumar Jain is the company secretary for Mankind Pharma Ltd.

  • RCJ
    RAMESH CHAND JUNEJAChairman & Wholetime Director
  • RJ
    RAJEEV JUNEJAVice Chairman & M.D.
  • SA
    SHEETAL ARORAWhole Time Director & CEO
  • TPO
    TILOKCHAND PUNAMCHAND OSTWALIndependent Director
  • BA
    Bharat AnandIndependent Director
  • SKS
    SATISH KUMAR SHARMAWhole-time Director
  • VK
    Vivek KalraIndependent Director
  • VS
    Vijaya SampathIndependent Director
  • HKJ
    Hitesh Kumar JainCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.